CDK7 antibody (Cyclin-Dependent Kinase 7)

Details for Product anti-CDK7 Antibody No. ABIN967506, Supplier: Log in to see
Antigen
  • CD 7
  • CDK7
  • CG3319
  • DmCDK7
  • DmCdk7
  • DmMO15
  • DmMo15
  • Dmcdk7
  • Dmel\\CG3319
  • Mo15
  • cdk-7
  • cdk7
  • dCdk7
  • p40[MO15]
  • MO15
  • cak1
  • stk1
  • cdkn7
  • p39mo15
  • p40MO15
  • CAK1
  • CDKN7
  • HCAK
  • STK1
  • p39MO15
  • AI323415
  • AI528512
  • C230069N13
  • Cdkn7
  • Crk4
  • zgc:85821
  • C-MOS
  • Cyclin-dependent kinase 7
  • cyclin-dependent kinase 7
  • v-mos Moloney murine sarcoma viral oncogene homolog
  • Cdk7
  • cdk7
  • CDK7
  • LOC100358882
  • MOS
Alternatives
anti-Human CDK7 antibody for Dot Blot
Reactivity
Human
202
55
33
11
9
8
8
6
2
2
2
2
1
1
1
Host
Mouse
142
62
3
Clonality (Clone)
Monoclonal ()
Conjugate
This CDK7 antibody is un-conjugated
10
8
6
6
6
6
2
2
1
Application
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (IF), Immunoprecipitation (IP), Western Blotting (WB)
183
95
72
42
32
21
19
17
16
10
6
3
3
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen Recombinant Human Cdk7
Clone MO-1
Isotype IgG2b
Characteristics 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
Purification Purified from tissue culture supernatant or ascites by affinity chromatography.
Alternative Name Cdk7 (CDK7 Antibody Abstract)
Background Cyclins and cyclin-dependent kinases (Cdks) are subunits of cell cycle dependent protein kinases that regulate key events during the cell cycle. For orderly progression to take place, Cdks must become fully active only at appropriate times in the cell cycle, and only in appropriate subcellular locations. For example, Cdk2 is activated during the S and G2 phases of the cell cycle and is associated with cyclins A and E. The monomeric form of Cdk2 is inactive as a kinase, its conformation has multiple steric impediments to catalysis. Activation occurs in two steps, and is accompanied by conformational changes that remove the steric hindrances. The first step is the binding of a single Cdk2 monomer to a single molecule of cyclin. This allows for some enzymatic activity, but full activation of Cdk2 and all other known Cdks requires phosphorylation of a conserved threonine residue. Cak (for Cdk-activating kinase) has been shown to phosphorylate the threonine residue and activate Cdk2/cyclin complexes. Cak is itself a cyclin/Cdk complex consisting of cyclin H and Cdk7. Cyclin H is the regulatory subunit of the Cak enzyme, whereas Cdk7 is the catalytic subunit. Thus, Cak functions as a regulator of other cyclin/kinase complexes, suggesting that cyclin/kinase cascades may exist. Cdk7 migrates as a single band at a reduced molecular weight of 36-42 kDa. The MO-1 antibody recognizes human Cdk7.5 Recombinant human Cdk7 was used as an immunogen.
Molecular Weight 40 kDa
Research Area Chromatin and Nuclear Signaling, Cell Cycle, Kinases/Phosphatases
Pathways Cell Division Cycle, DNA Damage Repair, Intracellular Steroid Hormone Receptor Signaling Pathway, Mitotic G1-G1/S Phases, M Phase
Application Notes Applications include western blot analysis (1-2 µg/ml). Other applications not routinely tested include immunoprecipitation (1 µg/ml cells), immunohistochemical staining of frozen tissue sections (1 µg/ml), and indirect immunofluorescence of tissue-cultured cells. The antibody is not recommended for immunohistochemical staining of paraffin-embedded tissue sections. HeLa human cervical carcinoma cells (ATCC CCL-2) or A-431 human epidermal carcinoma cells (ATCC CRL-1555) are suggested as positive immunoprecipitation and western blot controls.
Comment

Related Products: ABIN967389, ABIN968533, ABIN968535

Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/ml
Buffer Aqueous buffered solution.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Supplier Images
Western Blotting (WB) image for anti-CDK7 antibody (Cyclin-Dependent Kinase 7) (ABIN967506) Western blot analysis of Cdk7. Lysate from A-431 human epidermal carcinoma cells was ...
 image for anti-CDK7 antibody (Cyclin-Dependent Kinase 7) (ABIN967506) Frozen tissue section of human straified squamous carcinoma stained for Cdk7. A DAB c...
 image for anti-CDK7 antibody (Cyclin-Dependent Kinase 7) (ABIN967506) anti-Cyclin-Dependent Kinase 7 (CDK7) antibody (Image 3)
Product cited in: Solomon: "The function(s) of CAK, the p34cdc2-activating kinase." in: Trends in biochemical sciences, Vol. 19, Issue 11, pp. 496-500, 1995 (PubMed).

Serizawa, Mäkelä, Conaway, Conaway, Weinberg, Young: "Association of Cdk-activating kinase subunits with transcription factor TFIIH." in: Nature, Vol. 374, Issue 6519, pp. 280-2, 1995 (PubMed).

Fisher, Morgan: "A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase." in: Cell, Vol. 78, Issue 4, pp. 713-24, 1994 (PubMed).

Mäkelä, Tassan, Nigg, Frutiger, Hughes, Weinberg: "A cyclin associated with the CDK-activating kinase MO15." in: Nature, Vol. 371, Issue 6494, pp. 254-7, 1994 (PubMed).

Background publications Tassan, Schultz, Bartek, Nigg: "Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase)." in: The Journal of cell biology, Vol. 127, Issue 2, pp. 467-78, 1994 (PubMed).